Kidney Cancer

WASHINGTON (Reuters) - The U.S. Food and Drug Administration's review staff expressed doubts that GlaxoSmithKline Plc's experimental kidney cancer drug Votrient should be approved given concerns about liver injury, documents released on Thursday said. Votrient, also known by its chemical name pazopanib, aims to treat advanced renal cell carcinoma. But while the company's data showed a 5-month improvement in median progression-free survival, the FDA reviewers saw no "statistically significant improvement in overall survival." "FDA is concerned about the benefit-to-risk ratio of pazopanib in the intended population of patients. This is particularly true in a setting in which there are other effective products approved for ... Read Full Story

If you have a form of heart disease, maintaining a healthy lifestyle can be very difficult. We all need to eat healthy, maintain a good regular exercise routine and regular check-ups from our doctor. With heart disease, nor is the effect can be maintained on our kidneys can be disastrous. The task is to filter the blood of kidney carcinogens that we in everyday life by taking the very fine and remove processed foods. In addition, excess fluid removed from the bloodstream. The kidneys filter the blood flow to the waist of the natural pressure of the blood. When this excess fluid is not ... Read Full Story

The U.S. Food and Drug Administration today approved Votrient (pazopanib), the sixth drug to be approved for kidney cancer since 2005. Votrient is an oral medication that interferes with angiogenesis, the growth of new blood vessels needed for solid tumors to grow and survive. Votrient is intended for people with advanced renal cell carcinoma, a type of kidney cancer in which the cancerous cells are found in the lining of very small tubes (tubules) in the kidney. In 2009, approximately 49,000 people were diagnosed with renal cell carcinoma and 11,000 people died from the disease. “The last five years have seen dramatic improvements in ... Read Full Story

Alternative Kidney Cancer Treatment Author: john daniel Kidney cancer is the growth of malignant cells in the kidney. The two kidneys, located deep in the body at about the middle of the back, regulate the fluid and electrolyte balance into the urine. Urine collects in the portion of the kidney known as the renal pelvis; from there it passes through a narrow conduit (the ureter) to the bladder. There are three distinct types of kidney cancer: renal cell carcinoma (RCC) and transitional cell cancer (TCC) affect adults almost exclusively, while Wilms’ tumor usually affects children under age five. RCC (previously called hypernephroma), which arises ... Read Full Story

Sep 28, 2009 – Saint Louis, MO www.leebio.com , Lee Biosolutions, Inc has announced that it will increase its inventory and manufacturing capability of Human Cystatin C antigen which is fast becoming a renal protein marker of choice among researchers for early detection of acute renal failure because its unaffected by non-renal factors and demonstrates higher diagnostic accuracy and sensitivity . According to publish reports there are over 26 million adults who fall into high risk groups having some form of Chronic kidney disease. High risk groups include those with high blood pressure, diabetes and family history among others. If Chronic kidney disease is ... Read Full Story

It is not uncommon for people to lose up to 70 percent of their kidney function before developing any symptoms. Many of the causes of kidney failure strike at random, and cannot be predicted or prevented. To look on the bright side, the good thing about having early stage diabetes and hypertension is that they present an opportunity for early diagnosis and prevention of progression of kidney failure to end stage. The first signs may be general and can include: changes in frequency and quantity of urine passed, especially at night pain or burning when passing urine blood in the urine puffiness around the ... Read Full Story

Because early diagnosis is so critical to improving survival rates, those at risk for the disease need to be able to recognize kidney cancer symptoms. If you’re curious about whether you’re at risk for this cancer and any potential signs or symptoms you should watch out for, keep reading. Symptoms Bloody Urine: Bloody urine is a common sign of kidney cancer. However, like many kidney cancer symptoms, it can also be associated with bladder cancer and other bladder-related ailments. Back Pain: Many people diagnosed with kidney cancer experience low back pain that isn’t associated with an injury or other physical ailment. Lump or Bump: ... Read Full Story